AKI is supportive therapy. There are no drugs (therapeutic or preventive) that have been approved for the clinical treatment of AKI. 4 Therefore, there is a need to devise an effective therapy for AKI that can alleviate inflammatory response and promote renal regeneration.
The macrophages are multifunctional and heterogeneous innate immune cells, which play important roles in regulating inflammation. 5, 6 The mature macrophages can alter their phenotypes and undergo functional polarization in response to environmental signals. There are two well-known macrophage polarization programs: classically activated (M1) macrophages, which exhibit pro-inflammatory properties and alternatively activated (M2) macrophages, which are involved in tissue repair and resolution of inflammation. [7] [8] [9] The macrophages exhibit a spectrum of activated phenotypes rather than discrete stable subpopulations. The M1 and M2 macrophages represent two extreme phenotypic spectra with a continuum of intermediate phenotypes between M1 and M2 phenotypes. 10 The macrophages are reported to have pathogenic roles in human kidney diseases. After AKI, the neutrophils and natural killer cells are recruited to the damaged renal tissue within hours, which is followed by the infiltration of inflammatory monocytes. 11 These inflammatory monocytes are then polarized into M1 macrophages, which is mediated by various pro-inflammatory mediators, such as interleukin (IL)-1β, IL-6, tumour necrosis factor (TNF)-α and reactive oxygen species (ROS), to exacerbate early tubular injury. 8 However, during the later recovery phase, the macrophages switch to the M2 phenotype, which is involved in anti-inflammatory activities and tissue repair and remodelling. This indicated a protective role of M2 macrophages in tissue recovery. 8, 12 The M2 phenotype can be induced ex vivo or in vivo via IL-10 and transforming growth factor (TGF)-β stimulation for treating kidney diseases. 13 The type 2 innate lymphoid cells (ILC2s), which are a recently described innate immune cell population that can be activated by IL-33 or IL-25, also contribute to M2 polarization of macrophages through secretion of various type 2 cytokines, such as IL-4 and IL-13. [14] [15] [16] Recent studies have demonstrated that macrophages can be potentially used in cell therapies to induce immune tolerance to transplantation and to promote wound healing. 17, 18 Cao Q et al 13, 19 polarized the splenic macrophages to the M2 phenotype, which effectively reduced renal injury, by adoptive transfer of M2 macrophages to experimental models of adriamycin-induced kidney disease. Lee et al 12 demonstrated that the anti-inflammatory M2 macrophages promoted kidney repair after AKI. The CD11c + cells are reported to be involved in the recovery process after AKI. The depletion of macrophages by liposome clodronate treatment during the recovery phase was associated with persistent tubular damage and inflammation. 20 In an adriamycin nephrosis (AN) model, both M2a and M2c macrophages were reported to reduce renal inflammation. 21 However, it is difficult to obtain a large number of macrophages (approximately 10 6 cells/kg patient's weight) from the blood of the patients. Moreover, unlike T cells, macrophages are differentiated cells that cannot be expanded in vitro to meet the demand of cell therapy. 22 Therefore, there is a need to explore alternative sources of macrophages to meet the requirement of cell therapy.
Previous studies have reported that large numbers of monocytes/macrophages could be retrieved from effluent dialysis bags of patients undergoing peritoneal dialysis (PD). Approximately 40% of these cells are monocytes/macrophages. [23] [24] [25] [26] The macrophages from peritoneal dialysates are a rich source of mononuclear phagocytes that can be used for cell therapy. The phenotype of both human and mouse monocytes/macrophages could be polarized to the regulatory M2 phenotype by IL-4/IL-13. 27 The peritoneal M2 macrophages derived from peritoneal dialysates of mice markedly reduced the inflammatory infiltrates and kidney injury, while the peritoneal M1 macrophages exacerbated kidney injury in mice with AN. 19 However, the mechanism underlying peritoneal macrophage-mediated renal repair is not completely understood.
In this study, we aimed to evaluate the renal protective role of peritoneal M2 macrophage transplantation in hypoxia/reoxygenation (H/R)-induced renal proximal tubular epithelial cell (PTEC) injury and IRI-induced AKI in mice and evaluated the potential underlying mechanism.
| MATERIAL S AND ME THODS

| Mouse PD model
The mouse PD model was established as previously described. 28 The C57BL/6 mice were anaesthetized, and a silicon catheter (22 G) was inserted percutaneously into the left lower quadrant of the peritoneal cavity via a subcutaneous tunnel. The peritoneal fluid was drained, and the cells in the dialysate were collected every day for 15 days. The peritoneal macrophages from peritoneal dialysate were used in the following experiments.
| Macrophage isolation and M2 polarization
The macrophages derived from peritoneal dialysate of C57BL/6 mice were enriched using the CD11b + microbeads (Miltenyi Biotec). The enriched macrophages were cultured in the RPMI 1640 medium supplemented with 10% foetal bovine serum (FBS, Thermo Fisher Scientific), penicillin (50 U/mL), streptomycin (50 µg/mL) and macrophage colony-stimulating factor (M-CSF; 10 ng/mL, Invitrogen) overnight. The purity of macrophages was evaluated by flow cytometric analysis, which revealed >95% purity. The M0 macrophages were cultured for 48 hours in the presence of M-CSF and IL-4/IL-13 (20 ng/mL each, Invitrogen) to induce the M2 polarization.
| Isolation and culturing of PTECs
The mouse PTECs were isolated as described previously. 12 Briefly, the mice were anaesthetized with pentobarbital sodium (50 mg/kg). The capsule and medulla were excised using a sharp blade. The renal cortex, which was cut into 1 mm 3 pieces, was incubated with type IV collagenase (1 mg/mL, Roche) and DNase I (100 µg/mL, Roche) solution at 37°C for 40 minutes. The enzyme-containing solution was then removed. The digested cells were filtered through the 80-mesh and 100-mesh strainers. The cells were cultured in DME/F12 (Hyclone Laboratories) supplemented with 10% FBS, 50 U/mL penicillin and 50 µg/mL streptomycin in a humidified atmosphere at 37°C and 5% CO 2 . The PTECs were identified by immunofluorescence (IF) staining using the specific anti-cytokeratin 18 antibodies (1:1000, Servicebio, Sino Biological Inc).
| Cell co-culture and treatment
To induce H/R injury, the PTECs were subjected to hypoxia in a hypoxic chamber (≤1% O 2 , 5% CO 2 , 94% N 2 ) at 37°C for 24 hours, followed by reoxygenation (21% O 2 , 5% CO 2 , 74% N 2 ) for 2 hours. The PTECs were co-cultured with M0 or M2 macrophages under H/R conditions. For co-culture experiments, the M0 or M2 macrophages were seeded in a transwell insert at a density of 1.0 × 10 5 /cm 2 and cultured in the RPMI 1640 medium for 12 hours. The M0 or M2 macrophages were washed thrice with phosphate buffer solution (PBS) and then co-cultured with PTECs (ratio 1:1) in glucose and FBS-free Dulbecco's modified Eagle's medium (DMEM).
| Cell viability assay
The PTECs were seeded in a 96-well plate and co-cultured with M2 macrophages under H/R conditions. Next, the cells were incubated with CCK8 solution (Dojindo) for 2 hours at 37°C. The absorbance of the samples was measured at 450 nm using a microplate reader (BioTek Instruments Inc). The cell viability was calculated by normalizing the optical density of the experimental group to that of the control group.
| Quantitative real-time polymerase chain reaction (qPCR)
Total RNA was isolated from the renal tissues using Trizol (Gibco, Life Technologies), following the manufacturer's instructions. The isolated RNA was quantified using the NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific Inc). The RNA was reverse transcribed to cDNA using the iScript cDNA Synthesis kit (Bio-Rad).
The primer sequences are listed in Table S1 . The qPCR analysis was performed on a CFX96 Real-Time PCR Detection System (Bio-Rad) with SYBR green supermix (SsoFast EvaGreen, Bio-Rad). The relative change in the expression of target genes mRNA were calculated using the 2 -ΔΔCT method.
| Western blotting analysis
The cells and mouse renal tissues were homogenized in lysis buffer containing phenylmethanesulphonyl fluoride (PMSF). The protein concentrations were measured using the bicinchoninic acid (BCA) protein assay kit (Beyotime Biotechnology). Equal amount of protein was subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) using 10% gel. The resolved proteins were then transferred to a polyvinylidene difluoride membrane 
| Flow cytometric analysis
| Cell apoptosis assay
Cell apoptosis was analysed using the Annexin V-FITC/PI staining kit (Roche Applied Science). The treated cells were collected and labelled for 15 minutes with annexin V and propidium iodide (PI). The apoptotic cells were detected in a flow cytometer (Beckman Coulter).
| Cell cycle analysis
The treated cells were harvested, washed with cold PBS and fixed in 70% ethanol. Next, the cell samples were washed, resus- 
| IF staining
The cells were washed in PBS, fixed with 4% paraformaldehyde in PBS for 10 minutes, permeabilized with 0.1% Triton X-100 in PBS for 
| IRI mice model and cell treatment
| Biochemical measurement
The serum creatinine (CREA), blood urea nitrogen (BUN) and uric acid (UA) levels in the mice were analysed on an Automatic Biochemistry Analyzer (Cobas Integra 400 plus, Roche) using appropriate kits.
| Histological examination
The renal cross sections were subjected to haematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) staining. The tissue damage was examined and scored based on the percentage of damaged tubules as follows: 0, no damage; 1, <25%; 2, 25%-50%; 3, 50%-75%; 4, >75%. The samples were blinded to the assessor. The mean tubular injury scores for each mouse represented the average score of the 20 fields examined. [28] [29] [30] The expression levels of CD3, Ki67 and CDK (Santa Cruz Biotechnology) in the kidney tissues were evaluated by immunohistochemical (IHC) staining. The digital images of stained sections were captured under a light microscope (Zeiss Imager A2).
| Statistical analysis
Descriptive statistics were presented as mean ± standard error of mean (SEM) and analysed in the SPSS software (version 11.5, IBM Corp). All data were analysed using the Kolmogorov-Smirnov test to confirm the normal distribution. Student's t test was employed for comparisons between two groups. One-way analysis of variance (ANOVA) followed by Tukey's ad hoc test was used for multiple comparisons. All data were analysed using the two-tailed test. The difference was considered statistically significant when the P-value was <.05.
| RE SULTS
| Induction of peritoneal M2 macrophage in vitro
The phenotype of mononuclear cells obtained from peritoneal dialysates polarized to M0 macrophages upon induction with M-CSF and then to M2 macrophages upon induction with the combination of IL-4 and IL-13. As shown in Figure 1A , the M0 macrophages exhibited elongated shape, while the M2 macrophages exhibited round, oval or spindle shape. The FACS analysis revealed that the number of CD86 + M0 macrophages was similar to the number of CD86 + M2 macrophages. Additionally, the number of CD206 + M2 macrophages was markedly higher than the number of CD206 + M0 macrophages ( Figure 1B) . Compared with the M0 macrophages, the M2 macrophages exhibited higher mRNA expression levels of mannose receptor (Mr/Mrc1), Il10, Tgfb1, Arg1
and Ccl17 ( Figure 1C ).
| Peritoneal M2 macrophages attenuated renal injury in IRI mice
To determine the role of M2 macrophages in renal injury, we adoptively transplanted peritoneal macrophages into the kidneys of IRI mice. The detailed experimental scheme of animal study is shown in Figure 2A . The levels of renal function parameters, such as BUN, CREA and UA in the IRI mice (IRI group) and M0 macrophage-transplanted IRI mice (IRI + M0 group), were higher than those in the sham group. The levels of BUN, CREA and UA in the M2 macrophagetransplanted IRI mice (IRI + M2 group) were significantly lower than those in the sham group ( Figure 2B-D) . There was no significant difference between the levels of BUN, CREA and UA in the control group and PBS group ( Figure S4A ). The IRI group exhibited enhanced renal lesions, including tubular hypertrophy, loss of brush border, vacuolar degeneration and necrotic tubules when compared to the sham group (Figure 2E-F) . This indicated that the M2 macrophage transplantation decreased renal lesions in IRI mice, whereas M0 macrophage transplantation had no effect on renal injury in IRI mice.
| Peritoneal M2 macrophages attenuated renal inflammatory response in IRI mice
The macrophages were isolated from kidneys of the IRI group at day 3 post-transplantation. The flow cytometric analysis revealed that the number of CD206 + /CD11c + M2 macrophages in the kidneys of the IRI + M2 group was significantly higher than that in the IRI and IRI + M0 groups ( Figure 3A-B) . The flow cytometry gating strategy is shown in Figure S3A the number of CD4 + T cells and CD8 + T cells in the kidneys of IRI group was significantly higher than that in the kidneys of IRI + M2 group ( Figure 3F-G) . The flow cytometry gating strategy is shown in Figure S3B . To further validate the subtypes of macrophages, the M1 cells were subjected to co-immunostaining with F4/80 and iNOS, while the M2 cells were subjected to co-immunostaining with F4/80 and CD206. The IRI and IRI + M0 groups exhibited increased abundance of M1 macrophages, whereas the IRI + M2 group exhibited increased abundance of M2 macrophages ( Figure 4A-B ).
| Peritoneal M2 macrophages promoted tubular cell proliferation in IRI mice
The effect of M2 peritoneal macrophages on tubular epithelial cell proliferation after IRI was also analysed. The IHC staining analysis revealed that the levels of Ki67 and cyclin-dependent kinases (CDKs) in the kidneys of the IRI + M2 group were higher than those in the kidney of sham, IRI and IRI + M0 groups ( Figure 5A) .
Additionally, the IRI + M2 group exhibited higher protein and mRNA levels of CyclinD1 and CyclinD2 than the IRI and IRI + M0 
| Peritoneal M2 macrophages decreased cell apoptosis and expression of inflammatory factors in the PTECs under H/R conditions
The PTECs were isolated from the mouse renal cortex, and more than 95% of cells were positive for the epithelial marker (CK18) compared with the unstained control ( Figure S1A-C) . The cell viability of PTECs decreased significantly under H/R conditions, which improved upon co-culturing with M2 macrophages ( Figure 6C ). This was consistent with the cell proliferation rates determined by cell cycle assay ( Figure 6D ). The qPCR analysis revealed that the M2 macrophages 
| Peritoneal M2 macrophages promoted PTEC proliferation by activating the TGF-β/Smad7 pathway
The M2 macrophage transplantation could mitigate the decreased cell viability and proliferation index in the PTECs under H/R conditions. However, this proliferative effect was inhibited after treatment with anti-TGF-β (2 µg/mL, GeneTex) or TGF-β receptor inhibitor (10 µmol/L, Selleckchem) ( Figure 7A and D-G). The flow cytometry gating strategy is shown in Figure S3D . The qPCR and Western blotting analyses revealed that the M2 macrophages promoted the mRNA and protein expression of Smad7, CyclinD1 and CyclinD2 in the PTECs under H/R conditions, which was significantly mitigated with the addition of anti-TGF-β ( Figure 7B-C) .
The original images of Western blots are shown in Figure S2D .
Moreover, the inhibitory effect of M2 macrophages on cell apoptosis was also neutralized after treatment with anti-TGF-β or TGF-β receptor inhibitor ( Figure 7D-E) . The flow cytometry gating strategy is shown in Figure S3C . 
| D ISCUSS I ON
Despite the progress in renal replacement strategies, there are increased incidences of AKI and the mortality rate among patients with AKI remains high. 4 The macrophages are a key component of the innate immune system and play an important role in the initiation and progression of renal diseases. [31] [32] [33] [34] In this study, we established a PD mouse model to collect the peritoneal mononuclear cells and evaluated the protective effect of peritoneal M2 macrophage transplantation on AKI in vivo and in vitro. Our results indicated that the Previous studies have evaluated the therapeutic potential of macrophages. Autologous macrophages were used in a phase I human trial to treat spinal cord injury. The study revealed that autologous macrophages promote neurological recovery. 35 The regulatory macrophages induced by M-CSF and interferon (IFN)-γ were distinct from the conventional M2 phenotype, which could prolong the survival of heart allograft in mice. 36 Additionally, a clinical trial reported that these macrophages could suppress the T cells and consequently decrease the dose of immunosuppressive drugs required for kidney transplantation. 37 Qi et al evaluated the therapeutic potential of adoptive transfer of macrophages to treat kidney diseases and demonstrated the protective effects of different subsets of M2 macrophages and different sources of M2 macrophages in the experimental kidney disease models. 31 The study also explored the feasibility and efficacy of monocytes/macrophages from peritoneal dialysate of patients and mice. The adoptive transfer of peritoneal M2 macrophages derived from peritoneal dialysate of mice decreased renal inflammation and injury in mice with AN. 31 In this study, we demonstrated that the transplantation of peritoneal M2 macrophages derived from peritoneal dialysate of mice reduced renal inflammation and promoted tubular epithelial cell proliferation in IRI mice. These results suggested that the macrophages derived from peritoneal dialysate have potential therapeutic applications.
Inflammation is reported to be a key factor in the pathogenesis of AKI. 2 The macrophages are one of the major immune cells involved in inflammation. The M2 macrophages are generally activated at a later phase after the initial injury. In the ischaemic AKI model, enhanced expression of M2 markers was observed in the kidney after 3 days with peak expression observed after 7 days. [38] [39] [40] The M2 macrophages can be activated by M-CSF, IL-4, IL-10, IL-13 and TGF-β. The alternatively activated M2 macrophages have a diverse functional repertoire, contributing to wound healing, fibrosis, insulin sensitivity and immunosuppression. [41] [42] [43] [44] [45] [46] [47] The M2 macrophages are reported to promote tissue repair and remodelling in viral myocarditis and acute nephritis through secretion of various anti-inflammatory mediators, such as IL-4 and IL-10. 42, 43 Moreover, the peritoneal macrophages exhibited decreased secretion of TNF-α, IL-1β and IL-6 when compared to the peripheral macrophages. 44, 46 This suggested that the peritoneal macrophages have potential applications in cell therapy.
The results of this study demonstrated that the peritoneal M2 Renal tubular cell damage is an important mechanism underlying the pathogenesis of AKI. 44 Several studies have demonstrated that the macrophages play a reparative role during the recovery phase of AKI. [45] [46] [47] The depletion of macrophages during renal repair was associated with sustained renal inflammation and impaired tubular regeneration. 48 However, the mechanisms underlying the promotion of PTEC proliferation by the M2 macrophages in the post-ischaemic kidney are not well understood. The M2 macrophages are reported to promote cell proliferation by up-regulating Smad7 expression in the beta-cells. 49 Consistently, we observed significantly enhanced expression of Smad7, a TGF-β superfamily signalling inhibitor, in the renal tubular cells after AKI. Smad7 is reported to directly up-regulate the cell cycle activators, such as CyclinD1 and CyclinD2, which consequently promote beta-cell proliferation. 50 To further elucidate the underlying mechanism, we used an in vitro transwell system to co-culture the peritoneal macrophages and PTECs. Our results demonstrated that the M2 macrophages but not M0 macrophages were sufficient to induce Smad7 expression and consequently promote PTEC proliferation. The inhibition of the TGF-β/Smad7 signalling pathway using antibody or TGF-β receptor inhibitor markedly inhibited the PTEC proliferation under H/R conditions. Although the M2 macrophages are reported to be involved in tissue repair by promoting neovascularization and cell growth, 51 the results of this study indicated that they directly promote PTEC proliferation after AKI.
The peritoneal monocytes/macrophages derived from peritoneal dialysate are a rich source of M2 macrophages than can be used for cell therapy. Moreover, these cells can be polarized into different phenotypes for targeting different diseases. In this study, the adoptive transfer of peritoneal M2 macrophages mitigated renal dysfunction and inflammation after AKI. Additionally, the peritoneal M2 macrophages directly promoted the proliferation of renal tubular epithelial cells through the TGF-β/Smad7 signalling pathway. Therefore, the findings of this study indicated that autologous peritoneal macrophage-based cell therapy can be a potential treatment for kidney disease and other immunological and inflammatory diseases. Future studies must focus on evaluating the therapeutic potential of allogeneic peritoneal mononuclear cell-derived M2 macrophages for kidney injury.
| CON CLUS ION
Our study demonstrated that IRI induces severe renal inflamma- 
